Yik Yeung Lawrence Yu

Title: Yik Yeung Lawrence Yu: Innovator in Immunology

Introduction

Yik Yeung Lawrence Yu is a prominent inventor based in St. Louis, MO (US). He has made significant contributions to the field of immunology, particularly through his innovative work on single chain trimers. His research has the potential to advance therapeutic strategies for enhancing immune responses.

Latest Patents

Yik Yeung Lawrence Yu holds a patent for "Single chain trimers and uses therefor." This patent describes single chain trimer (SCT) molecules that comprise an MHC antigen peptide sequence, a β-microglobulin sequence, and a full-length MHC class I heavy chain sequence, all joined by linker sequences. The patent further details nucleic acids encoding these single chain trimers. Additionally, it outlines methods for expanding antigen-specific T cell populations using SCT molecules. These methods can achieve a remarkable 10,000-100,000 fold expansion of antigen-specific CD8+ T cells within approximately 28 days, yielding over 1 billion antigen-specific CD8+ T cells from a single donor.

Career Highlights

Yik Yeung Lawrence Yu is affiliated with Washington University, where he continues to conduct research and develop innovative solutions in immunology. His work has garnered attention for its potential applications in cancer therapy and vaccine development.

Collaborations

One of his notable collaborators is Ted H Hansen, with whom he has worked on various projects related to T cell expansion and immunotherapy.

Conclusion

Yik Yeung Lawrence Yu's contributions to the field of immunology through his patent on single chain trimers exemplify the impact of innovative research on advancing medical science. His work continues to inspire future developments in immune therapies.